Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations

OBJECTIVES: This study aims to investigate proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis (d-SSc) and its relation to disease activity, severity and subclinical atherosclerosis in such group of patients. PATIENTS AND METHODS: Between December 2019 and Ju...

Descripción completa

Detalles Bibliográficos
Autores principales: Artin, Joy, Elsabagh, Yumn A., Rashed, Laila, Hussein, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481689/
https://www.ncbi.nlm.nih.gov/pubmed/37680510
http://dx.doi.org/10.46497/ArchRheumatol.2023.9638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481689/
https://www.ncbi.nlm.nih.gov/pubmed/37680510
http://dx.doi.org/10.46497/ArchRheumatol.2023.9638

Ejemplares similares